Moomoo AI 已提取核心信息
Pfizer Inc. has alerted its shareholders of an unsolicited mini-tender offer by TRC Capital Investment Corporation to purchase up to 4 million shares of Pfizer's common stock at $27.35 per share. This offer price is approximately 4.4 percent below the closing price of Pfizer's stock on December 27, 2023. Pfizer has recommended that shareholders reject the offer, which it does not endorse, as it is below the current market price and subject to numerous conditions. The company has emphasized that it is not affiliated with TRC Capital or its offer and has advised shareholders to consult with their financial advisors. Shareholders who have already tendered shares have the option to withdraw them before the offer's expiration on January 30, 2024. Pfizer has also highlighted the risks associated with mini-tender offers, which are for less than 5 percent of a company's shares and are not subject to the same SEC regulations as larger tender offers.
Pfizer Inc. has alerted its shareholders of an unsolicited mini-tender offer by TRC Capital Investment Corporation to purchase up to 4 million shares of Pfizer's common stock at $27.35 per share. This offer price is approximately 4.4 percent below the closing price of Pfizer's stock on December 27, 2023. Pfizer has recommended that shareholders reject the offer, which it does not endorse, as it is below the current market price and subject to numerous conditions. The company has emphasized that it is not affiliated with TRC Capital or its offer and has advised shareholders to consult with their financial advisors. Shareholders who have already tendered shares have the option to withdraw them before the offer's expiration on January 30, 2024. Pfizer has also highlighted the risks associated with mini-tender offers, which are for less than 5 percent of a company's shares and are not subject to the same SEC regulations as larger tender offers.
辉瑞公司已提醒其股东，TRC资本投资公司主动提出了一项小型招标要约，即以每股27.35美元的价格购买辉瑞多达400万股普通股。该要约价格比辉瑞股票2023年12月27日的收盘价低约4.4％。辉瑞建议股东拒绝该提议，但它没有认可该要约，因为该要约低于当前的市场价格，而且有许多条件。该公司强调其与TRC Capital或其报价无关，并建议股东咨询其财务顾问。已经投标股票的股东可以选择在2024年1月30日要约到期之前撤回股票。辉瑞还强调了与小型招标要约相关的风险，这些要约涉及不到公司5％的股份，并且不受与更大规模的要约相同的美国证券交易委员会法规的约束。
辉瑞公司已提醒其股东，TRC资本投资公司主动提出了一项小型招标要约，即以每股27.35美元的价格购买辉瑞多达400万股普通股。该要约价格比辉瑞股票2023年12月27日的收盘价低约4.4％。辉瑞建议股东拒绝该提议，但它没有认可该要约，因为该要约低于当前的市场价格，而且有许多条件。该公司强调其与TRC Capital或其报价无关，并建议股东咨询其财务顾问。已经投标股票的股东可以选择在2024年1月30日要约到期之前撤回股票。辉瑞还强调了与小型招标要约相关的风险，这些要约涉及不到公司5％的股份，并且不受与更大规模的要约相同的美国证券交易委员会法规的约束。
有用
没用